159 related articles for article (PubMed ID: 21203907)
1. Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.
Fernández-Aceñero MJ; Córdova S; Manzarbeitia F; Medina C
Pathol Oncol Res; 2011 Sep; 17(3):519-23. PubMed ID: 21203907
[TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
[TBL] [Abstract][Full Text] [Related]
3. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
4. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
Ordóñez NG
Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
[TBL] [Abstract][Full Text] [Related]
5. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
[TBL] [Abstract][Full Text] [Related]
6. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.
Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL
Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334
[TBL] [Abstract][Full Text] [Related]
7. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
8. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
[TBL] [Abstract][Full Text] [Related]
9. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
Kaufmann O; Dietel M
Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
[TBL] [Abstract][Full Text] [Related]
11. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
12. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution.
Alijo Serrano F; Sánchez-Mora N; Angel Arranz J; Hernández C; Alvarez-Fernández E
Am J Clin Pathol; 2007 Nov; 128(5):733-9. PubMed ID: 17951193
[TBL] [Abstract][Full Text] [Related]
13. Primary Ureteral Thyroid Transcription Factor 1-Positive Small Cell Neuroendocrine Carcinoma: Case Report and Review of the Literature.
Acosta AM; Hamedani FS; Meeks JJ; Wu S
Int J Surg Pathol; 2015 Sep; 23(6):472-7. PubMed ID: 26162396
[TBL] [Abstract][Full Text] [Related]
14. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.
Matoso A; Singh K; Jacob R; Greaves WO; Tavares R; Noble L; Resnick MB; Delellis RA; Wang LJ
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):142-9. PubMed ID: 19887917
[TBL] [Abstract][Full Text] [Related]
15. Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases.
Soriano P; Navarro S; Gil M; Llombart-Bosch A
Virchows Arch; 2004 Sep; 445(3):292-7. PubMed ID: 15248064
[TBL] [Abstract][Full Text] [Related]
16. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
17. Small cell carcinoma of the urinary bladder.
Terada T
Int J Clin Exp Pathol; 2012; 5(6):596-600. PubMed ID: 22949944
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
[TBL] [Abstract][Full Text] [Related]
19. IMP3 expression in urothelial carcinomas of the urinary bladder.
Ozdemir NO; Türk NS; Düzcan E
Turk Patoloji Derg; 2011 Jan; 27(1):31-7. PubMed ID: 21469424
[TBL] [Abstract][Full Text] [Related]
20. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder.
Buza N; Cohen PJ; Pei Hui ; Parkash V
Int J Surg Pathol; 2010 Apr; 18(2):94-102. PubMed ID: 20164052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
